 "Covid-19: Cocktail of antibodies injection used first time in Andhra")
Samishta Hospital and Research Institute (SHRI), Guntur has administered cocktail antibodies injection 'Regeneron' to two patients. This is the first time the cocktail antibodies injection was used in Andhra Pradesh.
Dr Kalyana Chakravarti and the team administered the injection. Chakravarti said that both the patients are showing good improvement.
He said that patients are recovering well and will soon be discharged. The doctor said that they have stopped using high dose steroids while using 'Regeneron'.
Chakravarti further said that they have used stem cell therapy on 12 COVID-19 patients.
Using stem cell therapy is also giving good results, he said. While two patients are ready for discharge, five more patients in ICU are recovering well, he said. The doctor thanked the patients for helping in clinical research.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app